Peter leads in McKinsey’s Global Biopharmaceuticals Practice and was former head of the New Jersey office. Over his McKinsey career, Peter has helped leading companies in the pharmaceutical and medical products industries achieve their goals and stay competitive, having served clients in the US, Europe, Japan, and China. He currently leads the Firm’s biopharma advanced analytics (Quantum Black) team in North America. Peter partners with biopharmaceutical companies to tackle challenges like developing company- and business-unit-level strategies, optimizing portfolios, assessing and executing M&A transactions, and undertaking value-capture initiatives. Formerly leading our Clinical Development Practice, Peter also understands R&D, medical and related functions. In addition to serving large cap multi-national healthcare companies, Peter has supported biotech companies (small and mid-cap) on Its growth journey, including portfolio strategy, business development, functional excellence, commercialization and xUS market entry Initiatives. Peter has also supported various industry collaborations and associations, including BIO, DIA, and CPath.